Nephritic syndrome nursing: pathophysiology, assessment, and NCLEX review
Nephritic syndrome is a clinical syndrome caused by inflammatory damage to the glomeruli. Where nephrotic syndrome disrupts the protein barrier and floods the urine with albumin, nephritic syndrome disrupts the structural integrity of the glomerular wall — allowing red blood cells to cross into the urine. The result is a characteristic triad of hematuria, hypertension, and oliguria that every nursing student must recognize on sight.
This reference covers the pathophysiology, the classic triad, all major causes, the diagnostic workup, nursing assessment, interventions, and a head-to-head comparison with nephrotic syndrome — plus six NCLEX-style practice scenarios.
Quick reference: classic triad and key features
| Feature | Finding | Clinical clue |
|---|---|---|
| Hematuria | Cola-colored or tea-colored urine; RBC casts on microscopy | RBC casts are pathognomonic for glomerulonephritis |
| Hypertension | Elevated BP — often the most dangerous acute finding | Fluid/sodium retention from reduced GFR |
| Oliguria / azotemia | Urine output <400 mL/day; elevated BUN and creatinine | Reduced GFR from glomerular inflammation |
| Proteinuria | Mild to moderate (<3.5 g/24h) | Below the nephrotic threshold — a key distinguishing feature |
| Edema | Mild periorbital or peripheral edema | Less dramatic than nephrotic syndrome |
Mnemonic: Think of nephrItic as “I for Inflammation” — inflamed, bleeding glomeruli that reduce filtration.
Pathophysiology
Inflammatory glomerular injury
In nephritic syndrome, the primary insult is inflammation of the glomerulus — triggered by immune complex deposition, autoantibodies, or direct endothelial injury. The inflammatory response causes:
- Proliferation of mesangial, endothelial, and epithelial cells — the glomerulus becomes swollen and hypercellular, narrowing the capillary lumen and reducing blood flow through the glomerulus.
- Disruption of the glomerular capillary wall — inflammatory mediators increase permeability to red blood cells, allowing them to enter the filtrate. This produces hematuria and the characteristic RBC casts when those cells pass through the tubules.
- Reduced GFR — capillary lumen narrowing, cell proliferation, and glomerular inflammation collectively reduce the filtration rate. The kidney retains sodium and water, driving fluid accumulation and hypertension.
Resulting clinical findings
- Hematuria: dysmorphic (deformed) RBCs pass through the damaged glomerular wall. As they transit the tubules, they become trapped in protein casts — producing RBC casts, which are pathognomonic for glomerulonephritis on urinalysis.
- Hypertension: sodium and water retention from reduced GFR increases intravascular volume, elevating blood pressure. This can escalate to hypertensive urgency or emergency in severe cases.
- Oliguria and azotemia: reduced GFR means less waste is filtered. BUN and creatinine rise. In aggressive disease (RPGN), GFR can fall rapidly enough to require urgent dialysis.
- Variable proteinuria: the inflammatory process damages the glomerular barrier to protein as well, but less dramatically than in nephrotic syndrome. Proteinuria is typically sub-nephrotic (<3.5 g/24h) and sometimes mild (1–2 g/24h).
- Edema: milder than in nephrotic syndrome because hypoalbuminemia is not the primary driver; edema here reflects volume overload from impaired GFR and sodium retention.
This inflammatory mechanism is fundamentally different from the pure permeability defect of nephrotic syndrome — a distinction that explains why the two syndromes present so differently despite both involving the glomerulus.
Classic presentation
Hematuria
Patients (or parents, in pediatric cases) often describe urine that is brown, tea-colored, or cola-colored — this is the visual result of hemoglobin oxidation in urine. It may be intermittent or persistent. Microscopic hematuria (>5 RBCs/high-power field) is present even when gross discoloration is absent.
Dysmorphic RBCs — particularly acanthocytes (spiky, deformed red cells) — indicate glomerular origin of the bleeding and differentiate nephritic hematuria from lower urinary tract bleeding (UTI, stones, tumor), where RBCs are typically normal-shaped.
RBC casts form when RBCs enter the tubular lumen and become embedded in the Tamm-Horsfall protein matrix. Their presence on urine microscopy is pathognomonic for glomerulonephritis and is one of the most tested NCLEX urinalysis findings.
Hypertension
Hypertension in nephritic syndrome is driven by sodium and water retention from reduced GFR, and by activation of the renin-angiotensin-aldosterone system (RAAS). Blood pressure is often significantly elevated and can progress to hypertensive encephalopathy (headache, confusion, seizures) in severe cases — making BP monitoring a top nursing priority.
Oliguria and azotemia
Reduced urine output reflects impaired filtration. Nitrogen waste products (BUN, creatinine) accumulate in the bloodstream — this is azotemia. In mild nephritic syndrome, BUN and creatinine rise modestly. In RPGN (see below), azotemia can progress to frank acute kidney injury within days to weeks.
Causes and types
Nephritic syndrome is a shared clinical presentation produced by several distinct diseases. The cause determines the complement pattern, serologies, prognosis, and treatment.
| Cause | Typical patient | Latency / timing | Key serologies | Complement | Treatment focus |
|---|---|---|---|---|---|
| Post-streptococcal GN (PSGN) | Children; adults after strep skin infection | Throat: 1–3 weeks; skin (impetigo): 2–6 weeks | ↑ ASO titer, ↑ anti-DNase B | Low C3, normal C4 | Supportive; antibiotics only if active infection |
| IgA nephropathy (Berger’s disease) | Young adults; males > females | Concurrent (synpharyngitic) — hematuria during or immediately after URI | IgA elevated in ~50%; no ASO rise | Normal C3, C4 | ACE inhibitors/ARBs; corticosteroids in progressive disease |
| Rapidly progressive GN (RPGN) — immune complex | Variable | Subacute onset | ANA, anti-dsDNA, low complement (lupus); ANCA negative | Variable (low in lupus class III/IV) | High-dose corticosteroids ± cyclophosphamide |
| RPGN — pauci-immune (ANCA-associated) | Adults, often >50s | Subacute; weeks | c-ANCA (PR3) in granulomatosis with polyangiitis; p-ANCA (MPO) in MPA | Normal C3, C4 | Corticosteroids + cyclophosphamide or rituximab; plasmapheresis in severe cases |
| Anti-GBM disease (Goodpasture syndrome) | Young men (pulmonary-renal); older adults | Rapid, days to weeks | Anti-GBM antibodies positive | Normal C3, C4 | Plasmapheresis + corticosteroids + cyclophosphamide; urgent |
| Lupus nephritis (Class III/IV) | Women of childbearing age | Variable | ANA, anti-dsDNA, anti-Smith | Low C3 and C4 | High-dose corticosteroids + mycophenolate or cyclophosphamide |
| Membranoproliferative GN (MPGN) | Variable | Variable | Low C3; may have cryoglobulins, hepatitis C Ab | Low C3 ± C4 | Treat underlying cause; immunosuppression |
PSGN: the classic pediatric nephritic syndrome
Post-streptococcal glomerulonephritis is the most common cause of acute nephritic syndrome in children, typically ages 5–12. It follows infection with nephritogenic strains of Group A beta-hemolytic Streptococcus (particularly M-protein types 12, 4, and 1).
The latency period is critical to know:
- Streptococcal pharyngitis (strep throat): 7–21 days after infection before renal symptoms appear
- Streptococcal skin infection (impetigo): 2–6 weeks after infection
This latency distinguishes PSGN from IgA nephropathy. The immune complexes deposit in the subepithelial space, activate complement (particularly C3), and trigger the inflammatory response.
Prognosis in children is excellent — most recover full renal function within weeks to months. Adults with PSGN have a higher rate of persistent proteinuria and hypertension.
IgA nephropathy: the most common adult GN
IgA nephropathy (Berger’s disease) is the most common primary glomerulonephritis worldwide. It is caused by deposition of galactose-deficient IgA1 immune complexes in the glomerular mesangium.
The defining clinical feature is synpharyngitic hematuria — hematuria that occurs simultaneously with, or within 1–3 days of, an upper respiratory infection. There is no latency period. This is the key differentiating feature from PSGN on NCLEX.
Course varies: some patients have recurrent episodes of hematuria and remain stable for decades; others progress to CKD over years.
RPGN: glomerulonephritis as emergency
Rapidly progressive glomerulonephritis (RPGN) is defined by rapid loss of renal function — typically a 50% decline in GFR within weeks. Biopsy shows crescent formation: proliferation of parietal epithelial cells in the Bowman capsule compresses the glomerular tuft and destroys filtration function.
RPGN is a medical emergency requiring immediate nephrology involvement. The three immunopathological types are:
- Type I (anti-GBM): Linear IgG deposits along the GBM; Goodpasture syndrome when lungs are also involved (pulmonary hemorrhage + glomerulonephritis)
- Type II (immune complex): Granular deposits — lupus, IgA nephropathy, PSGN
- Type III (pauci-immune / ANCA-associated): Little or no immune deposits; caused by ANCA vasculitis (GPA, MPA)
Nephritic vs nephrotic syndrome: comparison table
This is the highest-yield NCLEX comparison in renal nursing. Both syndromes arise from glomerular damage, but the mechanism, urine findings, and clinical picture differ substantially.
| Feature | Nephritic syndrome | Nephrotic syndrome |
|---|---|---|
| Primary mechanism | Glomerular inflammation → endothelial/mesangial damage → RBC leakage + reduced GFR | Glomerular permeability defect → podocyte/GBM damage → massive protein leakage |
| Proteinuria | Mild to moderate (<3.5 g/24h) | Massive (>3.5 g/24h) — defining feature |
| Hematuria | Present — dysmorphic RBCs, RBC casts; cola/tea-colored urine | Minimal or absent |
| Urine appearance | Tea-colored, cola-colored (gross hematuria) | Frothy, foamy (high protein) |
| Hypoalbuminemia | Mild or absent | Significant (<3.0 g/dL) — defining feature |
| Edema | Mild periorbital or peripheral edema; volume overload | Generalized — periorbital, dependent, ascites, pleural effusion |
| Hypertension | Prominent — sodium/water retention from reduced GFR | Mild if present; more prominent in secondary causes |
| Oliguria / azotemia | Present — reduced GFR; BUN and creatinine elevated | Mild; GFR relatively preserved in most primary causes |
| Lipiduria / hyperlipidemia | Absent or minimal | Present — oval fat bodies, Maltese crosses; hypercholesterolemia |
| Key urine finding | RBC casts (pathognomonic for GN); dysmorphic RBCs | Oval fat bodies; fatty casts; heavy proteinuria on dipstick |
| Complement levels | Low C3 in PSGN, MPGN, lupus; normal in IgA nephropathy, anti-GBM, ANCA vasculitis | Normal in most primary causes; low C3/C4 in lupus nephritis |
| Common causes | PSGN, IgA nephropathy, RPGN, lupus nephritis Class III/IV, anti-GBM disease, MPGN | Minimal change disease, FSGS, membranous nephropathy, diabetic nephropathy |
| Primary treatment focus | Antihypertensives, fluid/sodium restriction, immunosuppression (cause-dependent), plasmapheresis (anti-GBM/ANCA) | Corticosteroids, ACE inhibitors/ARBs, diuretics, anticoagulation if albumin critically low |
Diagnostic workup
Urinalysis — the first and most important test
| Finding | Significance |
|---|---|
| RBC casts | Pathognomonic for glomerulonephritis — always indicates glomerular origin |
| Dysmorphic RBCs / acanthocytes | Confirms glomerular hematuria; differentiates from lower UTI bleeding |
| Granular casts | Nonspecific; seen with tubular damage accompanying glomerular disease |
| Proteinuria (1–3+) | Present but sub-nephrotic; 1–3 g/24h range typical |
| Cola/tea-colored appearance | Gross hematuria from RBC breakdown products (hemoglobin oxidation) |
A urine dipstick positive for blood with RBC casts on microscopy is the combination that flags nephritic syndrome immediately.
Serum labs
| Test | What it tells you | Elevated / decreased in |
|---|---|---|
| BUN, creatinine | GFR impairment | Elevated — all nephritic syndrome |
| C3 complement | Complement pathway activation | Low in PSGN, MPGN, lupus nephritis |
| C4 complement | Classical pathway activation | Low in lupus nephritis; normal in PSGN (alternative pathway) |
| ASO titer, anti-DNase B | Recent Group A strep infection | Elevated in PSGN |
| ANA, anti-dsDNA | Systemic lupus erythematosus | Elevated in lupus nephritis |
| ANCA (c-ANCA/p-ANCA) | Systemic vasculitis | Elevated in GPA (c-ANCA/PR3) or MPA (p-ANCA/MPO) |
| Anti-GBM antibodies | Anti-GBM disease / Goodpasture syndrome | Elevated in Goodpasture |
| Serum albumin | Protein loss and nutritional status | Low in nephrotic; near-normal in nephritic |
Complement pattern as a diagnostic shortcut:
- Low C3, normal C4 → PSGN or MPGN (alternative complement pathway activation)
- Low C3 and C4 → Lupus nephritis (classical pathway)
- Normal C3 and C4 → IgA nephropathy, anti-GBM disease, ANCA vasculitis
Renal biopsy
Renal biopsy is the definitive diagnostic tool for most causes of nephritic syndrome. It provides:
- Light microscopy: hypercellularity pattern, crescent formation (RPGN), mesangial expansion (IgA), subepithelial humps (PSGN)
- Immunofluorescence: IgG linear (anti-GBM), IgA mesangial (IgA nephropathy), granular C3/IgG (PSGN, lupus)
- Electron microscopy: location of deposits (subepithelial, subendothelial, mesangial)
Nursing assessment
Vital signs and cardiovascular monitoring
Blood pressure is the single most critical monitoring parameter in nephritic syndrome. Hypertension can escalate rapidly to hypertensive urgency (>180/120 mmHg) or hypertensive emergency (end-organ damage: encephalopathy, pulmonary edema, retinal hemorrhage). Monitor BP every 1–4 hours in the acute phase, or per unit protocol.
Assess for signs of hypertensive encephalopathy: severe headache, confusion, visual disturbances, nausea and vomiting, seizures. These require immediate escalation.
Fluid balance
- Intake and output (I&O): strict measurement every shift. Oliguria (<400 mL/day or <0.5 mL/kg/hr) signals worsening GFR — escalate to the provider.
- Daily weights: weigh at the same time daily in similar clothing. A gain of >1 kg/day indicates fluid retention.
- Edema assessment: document location, grade (1+ to 4+), and trend. Assess for sacral edema in supine patients.
- Lung sounds and respiratory status: volume overload can produce pulmonary edema — assess for crackles, decreased O₂ saturation, and work of breathing.
Urinalysis monitoring
Recognize the visual cues: cola-colored or tea-colored urine in a patient with recent strep throat or an upper respiratory infection should immediately raise the concern for nephritic syndrome. Document urine color at every assessment.
Laboratory trends
Monitor BUN and creatinine at each lab draw. A rising creatinine signals worsening GFR. In RPGN, creatinine can double within days — communicate rapid rises to the provider immediately. Reference nursing lab values for normal ranges and critical thresholds.
Monitor electrolytes: reduced GFR impairs potassium excretion → risk of hyperkalemia. Monitor for EKG changes if potassium is elevated (peaked T waves, widened QRS — see electrolyte imbalances reference).
Nursing interventions
Antihypertensive therapy
ACE inhibitors (e.g., lisinopril) and ARBs (e.g., losartan) are first-line antihypertensives in nephritic syndrome. They serve dual purposes:
- Blood pressure control
- Reduction of proteinuria and glomerular hyperfiltration pressure — nephroprotective effect
Nursing considerations for ACE inhibitors/ARBs:
- Monitor potassium — hyperkalemia risk, especially with reduced GFR
- Monitor creatinine — a rise of up to 30% above baseline is expected and acceptable; higher rises or rising serum potassium require provider notification
- Avoid in bilateral renal artery stenosis
- Hold in acute kidney injury with oliguria (may worsen GFR acutely)
If immediate blood pressure reduction is needed, IV antihypertensives (labetalol, hydralazine, nicardipine) may be used in the inpatient setting.
Fluid and sodium restriction
- Sodium restriction (2 g/day) — reduces fluid retention, lowers BP, and decreases edema. Educate patients to avoid processed foods, canned soups, and added salt.
- Fluid restriction — individualized based on urine output, edema severity, and degree of oliguria. Common starting point: fluid intake = previous day’s urine output + ~500 mL for insensible losses.
Diuretic therapy
Loop diuretics (furosemide, bumetanide) are used for fluid overload and edema. Monitor:
- Urine output response
- Electrolytes (risk of hypokalemia, hyponatremia, hypomagnesemia)
- Creatinine (over-diuresis can worsen GFR in a patient who is already oliguric)
- Signs of orthostatic hypotension (dizziness, lightheadedness)
Immunosuppressive therapy
Many causes of nephritic syndrome require cause-specific immunosuppression:
| Cause | Immunosuppression | Notes |
|---|---|---|
| Lupus nephritis Class III/IV | High-dose corticosteroids + mycophenolate mofetil or cyclophosphamide | Monitor CBC, glucose, infection risk |
| RPGN (immune complex or ANCA) | High-dose IV methylprednisolone (pulse) + cyclophosphamide or rituximab | Urgent; requires early nephrology |
| Anti-GBM disease (Goodpasture) | Corticosteroids + cyclophosphamide + plasmapheresis | Plasmapheresis removes circulating anti-GBM antibodies |
| ANCA-positive RPGN | Corticosteroids + cyclophosphamide or rituximab ± plasmapheresis | Used if pulmonary hemorrhage or dialysis dependence |
| IgA nephropathy (progressive) | ACE inhibitors/ARBs as first-line; corticosteroids if GFR declining | SGLT2 inhibitors emerging as kidney-protective in CKD |
Key nursing considerations for immunosuppression:
- Corticosteroids: monitor blood glucose (steroid hyperglycemia), BP, weight, mood changes; never stop abruptly
- Cyclophosphamide: ensure adequate hydration to prevent hemorrhagic cystitis; monitor CBC for myelosuppression; infection precautions
- Rituximab: premedicate before infusion (acetaminophen + diphenhydramine); screen for hepatitis B before initiating; monitor for infusion reactions
Antibiotic therapy in PSGN
Antibiotics (typically penicillin or amoxicillin) are given in PSGN if active streptococcal infection is still present. This is a critical NCLEX distinction: antibiotics eradicate the streptococcal organism and prevent transmission to others — they do not reverse or accelerate recovery from the glomerulonephritis itself. The kidney inflammation is immune-mediated and runs its own course.
Plasmapheresis
Plasmapheresis (therapeutic plasma exchange) physically removes pathogenic antibodies from the circulation. It is used in:
- Anti-GBM disease (Goodpasture syndrome): removes circulating anti-GBM antibodies before they cause further kidney and lung damage
- ANCA-positive RPGN with pulmonary hemorrhage or dialysis dependence
Nursing considerations: vascular access (large-bore catheter or apheresis catheter), monitor for citrate-related hypocalcemia (numbness, tingling, tetany), allergic reactions, and hypotension during the procedure.
NCLEX practice questions
Question 1
A nurse is admitting an 8-year-old with cola-colored urine, BP 148/96 mmHg, and periorbital edema. The parent reports the child had a sore throat 2 weeks ago that was treated at home. Which diagnosis should the nurse anticipate?
A) Nephrotic syndrome B) Post-streptococcal glomerulonephritis C) IgA nephropathy D) Urinary tract infection
Answer: B
Rationale: The combination of cola-colored urine (hematuria), hypertension, edema, and a streptococcal infection 2 weeks prior is the classic presentation of PSGN. The latency period (1–3 weeks after strep pharyngitis) is a key distinguishing feature. Nephrotic syndrome would present with frothy urine, massive proteinuria, and significant hypoalbuminemia — not cola-colored urine. IgA nephropathy causes hematuria concurrently with (not 2 weeks after) a URI. A UTI would not cause hypertension or the latency pattern described.
Question 2
A nurse reviews urine microscopy results for a patient with suspected glomerulonephritis. Which finding is pathognomonic for glomerulonephritis?
A) Waxy casts B) Granular casts C) RBC casts D) WBC casts
Answer: C
Rationale: RBC casts are pathognomonic for glomerulonephritis — their presence confirms that red blood cells entered the tubular lumen from a glomerular source and became embedded in the tubular protein matrix. Waxy casts indicate advanced renal failure/CKD. Granular casts are nonspecific markers of tubular damage. WBC casts indicate interstitial nephritis or pyelonephritis (white cell infiltration of the tubule, typically from infection or drug reaction).
Question 3
A 24-year-old male presents to the ED with sudden onset of tea-colored urine. He reports he has had a “bad cold” for the past two days. He has no history of sore throat in the past several weeks. Which condition is most consistent with this presentation?
A) Post-streptococcal GN — 3-week latency pattern B) IgA nephropathy — synpharyngitic hematuria C) Anti-GBM disease — hemoptysis with hematuria D) Lupus nephritis — ANA-positive
Answer: B
Rationale: Hematuria that occurs simultaneously with or within 1–3 days of an upper respiratory infection is the hallmark of IgA nephropathy (synpharyngitic hematuria). There is no latency period. This distinguishes it from PSGN, where hematuria appears 1–3 weeks after the strep infection resolves. This patient’s onset during the URI (not weeks after) points directly to IgA nephropathy.
Question 4
A patient with acute nephritic syndrome has a blood pressure of 172/104 mmHg. Which nursing action is the highest priority?
A) Encourage oral fluid intake to dilute the urine B) Administer the prescribed antihypertensive and reassess BP within 30–60 minutes C) Place the patient in Trendelenburg position D) Restrict protein intake to 1.5 g/kg/day
Answer: B
Rationale: Hypertension is the most acutely dangerous component of nephritic syndrome and the priority nursing intervention. At 172/104 mmHg, this patient is at risk for hypertensive urgency — and could develop hypertensive encephalopathy (headache, confusion, seizures) or pulmonary edema. Administer the prescribed antihypertensive and reassess BP promptly. Increasing fluid intake would worsen hypertension and volume overload. Trendelenburg (legs elevated, head down) increases venous return and would worsen hypertension. Protein restriction is a dietary measure with no immediate impact on acute hypertension.
Question 5
A child with post-streptococcal GN is prescribed a 10-day course of penicillin. The child’s parent asks: “Will the antibiotic help my child’s kidneys get better?” Which response by the nurse is most accurate?
A) “Yes, the antibiotic kills the bacteria that are attacking the kidneys.” B) “The antibiotic will clear any remaining strep infection, but the kidney inflammation will heal on its own over weeks to months.” C) “Penicillin reverses the kidney damage if given within the first 48 hours.” D) “The antibiotic prevents the kidneys from getting worse, so it should stop the hematuria quickly.”
Answer: B
Rationale: Antibiotics in PSGN serve to eradicate any remaining streptococcal infection and prevent spread to others. They do not reverse, accelerate, or directly treat the glomerulonephritis itself. The kidney inflammation is immune-mediated — the immune complexes were already deposited before symptoms appeared, so removing the bacteria now does not clear the renal lesion. PSGN in children typically resolves over weeks to months with supportive care (antihypertensives, fluid restriction, sodium restriction).
Question 6
A 55-year-old patient presents with three weeks of worsening hematuria, fatigue, and oliguria. Today’s creatinine is 4.8 mg/dL, up from 2.1 mg/dL one week ago. Urinalysis shows RBC casts and 2+ proteinuria. ANCA testing is pending. Which action is most urgent?
A) Schedule renal biopsy for next week B) Initiate oral prednisone and reassess in one month C) Contact the nephrologist immediately — this presentation is consistent with RPGN D) Order a renal ultrasound and repeat labs in 48 hours
Answer: C
Rationale: The combination of rapidly worsening azotemia (creatinine more than doubling in one week), oliguria, RBC casts, and a sub-acute onset is the clinical signature of rapidly progressive glomerulonephritis (RPGN). RPGN is a nephrological emergency — without immediate evaluation and treatment (pulse corticosteroids, immunosuppression, and possibly plasmapheresis), patients can progress to dialysis-dependent kidney failure within days to weeks. Waiting a week for biopsy, or reassessing in one month, would be dangerous. The urgency of nephrology consultation cannot be overstated when creatinine is rising this rapidly in the context of glomerulonephritis findings.
Summary
Nephritic syndrome is an inflammatory glomerular syndrome defined by its classic triad — hematuria (with RBC casts), hypertension, and oliguria/azotemia. Its mechanism differs from nephrotic syndrome at a fundamental level: this is inflammatory destruction, not a protein permeability defect, which is why urine findings, clinical features, and treatment approaches diverge.
Key takeaways for NCLEX and clinical practice:
- RBC casts = pathognomonic for glomerulonephritis — this is the single most tested urinalysis finding in renal nursing
- Cola-colored urine + 1–3 week post-strep latency = PSGN — most common in children, excellent prognosis
- Hematuria concurrent with URI (no latency) = IgA nephropathy — most common GN in adults worldwide
- Rapidly rising creatinine + RBC casts = RPGN until proven otherwise — emergency, call nephrology immediately
- Antibiotics in PSGN eradicate strep; they do not reverse the glomerulonephritis
- Hypertension is the most acutely dangerous feature — monitor closely and treat aggressively
For the full side-by-side comparison with nephrotic syndrome, see the nephrotic syndrome nursing reference. For acute kidney injury staging and management — which can complicate severe nephritic syndrome — see the AKI reference. For CKD progression and monitoring, see CKD and ESRD nursing.
Reviewed by Lindsay Smith, AGPCNP. Clinical references: StatPearls — Nephritic Syndrome (NBK562240); StatPearls — Rapidly Progressive Glomerulonephritis (NBK557430); KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases; National Kidney Foundation clinical practice guidelines.